Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Propionate/Salmeterol in Patients with Asthma

Study Title

Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma

Teva Identifier

FSS-AS-305

ClinicalTrials.gov Identifier

NCT02175771

Study Status

Completed

Trial Condition(s)

Persistent Asthma

Interventions

Drug: Fp MDPI | Drug: FS MDPI | Drug: FLOVENT HFA | Drug: ADVAIR DISKUS | Drug: albuterol/salbutamol HFA

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

07/01/2014 - 07/01/2015

Phase

Phase 3

Study Type

Interventional